Drug: gemcitabine Quarter: 2016Q3
Total Records: 1,060 Number of Pages: 53
DRUGNAME | PT | EventCount |
---|---|---|
GEMCITABINE HYDROCHLORIDE. | Infusion site pain | 6 |
GEMCITABINE HYDROCHLORIDE. | Malignant neoplasm progression | 6 |
GEMCITABINE HYDROCHLORIDE. | Pain | 6 |
GEMCITABINE HYDROCHLORIDE. | Pleural effusion | 6 |
GEMCITABINE HYDROCHLORIDE. | Second primary malignancy | 6 |
GEMCITABINE HYDROCHLORIDE. | Toxicity to various agents | 6 |
GEMCITABINE | Abdominal pain lower | 5 |
GEMCITABINE | Bile duct obstruction | 5 |
GEMCITABINE | Breast pain | 5 |
GEMCITABINE | Cardiac failure | 5 |
GEMCITABINE | Condition aggravated | 5 |
GEMCITABINE | Deep vein thrombosis | 5 |
GEMCITABINE | Energy increased | 5 |
GEMCITABINE | Epistaxis | 5 |
GEMCITABINE | Escherichia sepsis | 5 |
GEMCITABINE | Eye disorder | 5 |
GEMCITABINE | Febrile infection | 5 |
GEMCITABINE | Gastritis | 5 |
GEMCITABINE | Gastrointestinal disorder | 5 |
GEMCITABINE | Gout | 5 |
Total Records: 1,060 Number of Pages: 53